科笛-B2025年收益增长20.2%,亏损较上年同期收窄

公告速递
Mar 24

截至2025年12月31日止年度,科笛-B的收益约为人民币3.36152亿元(较2024年的2.79615亿元增长约20.2%),此增幅主要来自毛发疾病及护肤产品销售的提升,并且2025年下半年收益较上半年环比增长约307%。同期销售成本约为1.40360亿元,毛利约1.95792亿元,毛利率由上年度的51%上升至约58%,反映高毛利产品销售贡献增加及持续的成本管控。

销售及分销支出约2.18370亿元,同比减少约17.2%;研发成本约1.48652亿元,同比下降约25.3%;行政开支约1.28917亿元,较上年下降约9.1%;财务成本则由0.10860亿元减少至0.09712亿元。报告期内亏损约3.40192亿元,相较2024年的4.33811亿元有所收窄。集团于期末的资产负债率为32.2%,上年同期为30.0%。

于2025年12月31日,集团总资产约10.36561亿元,流动资产约10.42650亿元,非流动资产约2.63626亿元,总负债约1.51280亿元,权益总额约8.85281亿元。现金及现金等价物及三个月以上定期存款等金融资产合计约7.88亿元,其中现金及现金等价物约2.65006亿元、按公平值计入损益的金融资产约4.31488亿元,以及三个月以上的定期存款约0.91747亿元。流动比率由2024年的约2.4倍上升至2025年的约2.9倍,短期偿付能力保持稳健。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10